Acetaminophen reinforces descending inhibitory pain pathways

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 1, 2008, Pages 47-51

  Pickering, G ^a,b   Esteve V ^a   Loriot, M A ^c,d   Eschalier, A ^a,b   Dubray, C ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSERM   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; PLACEBO; SODIUM CHLORIDE; TROPISETRON;

ADULT; ANALGESIA; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG COMPETITION; DRUG EFFECT; DRUG METABOLISM; HUMAN; MALE; NORMAL HUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE;

ACETAMINOPHEN; ADULT; AREA UNDER CURVE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PYRAMIDAL TRACTS;

EID: 45549093197     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100403     Document Type: Article

References (36)

1. Pelissier, T., Alloui, A., Paeile, C. & Eschalier, A. Evidence of a central antinociceptive effect of acetaminophen involving spinal 5HT3 receptors. NeuroReport 6, 1546-1548 (1995).
2. Alloui, A. et al. Acetaminophen exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur. J. Pharmacol. 443, 71-77 (2002).
3. Tjolsen, A., Lund, A. & Hole, K. Antinociceptive effect of acetaminophen in rats is partly dependent on spinal serotonergic systems. Eur. J. Pharmacol. 193, 193-201 (1991).
4. Pini, L.A., Sandrini, M. & Vitale, G. The antinociceptive action of acetaminophen is associated with changes in the serotonergic system in the rat brain. Eur. J. Pharmacol. 308, 31-40 (1996).
5. Bonnefont, J., Chapuy, E., Clottes, E., Alloui, A. & Eschalier, A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114, 482-490 (2005).
6. Pickering, G., Loriot, M.A., Libert, F., Eschalier, A., Beaune, P. & Dubray, C. Paracetamol: first evidence of a central serotonergic mechanism of action in humans. Clin. Pharmacol. Ther. 79, 371-378 (2006).
7. Millan, M.J. Descending control of pain. Prog. Neurobiol. 66, 355-474 (2002).
8. Willer, J.C., Roby, A. & Le Bars, D. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain 107, 1095-1112 (1984).
9. Price, D.D. & McHaffie, J.G. Effects of heterotopic conditioning stimuli on first and second pain: a psychophysical evaluation in humans. Pain 34, 245-252 (1988).
10. Talbot, J.D., Duncan, G.H. & Bushnell, M.C. Effects of diffuse noxious inhibitory controls (DNICs) on the sensory-discriminative dimension of pain perception. Pain 36, 231-238 (1989).
11. Le Bars, D., Dickenson, A.H. & Besson, J.M. Diffuse noxious inhibitory controls (DNIC). Part II. Lack of effect on non-convergent neurons, supraspinal involvement and theoretical implications. Pain 6, 305-327 (1979).
12. Washington, L.L., Gibson, S.J. & Helme, R.D. Age-related differences in the endogenous analgesic response to repeated cold water immersion in human volunteers. Pain 89, 89-96 (2000).
13. Edwards, R.R., Fillingim, R.B. & Ness, T.J. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 101, 155-165 (2003).
14. Julien, N. & Marchand, S. Endogenous pain inhibitory systems activated by spatial summation are opioid-mediated. Neurosci. Lett. 401, 256-260 (2006).
15. Willer, J.C., Le Bars, D. & De Broucker, T. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur. J. Pharmacol. 182, 347-355 (1990).
16. Zhang, Y.Q., Gao, X., Zhang, L.M. & Wu, G.C. The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan inflammation. NeuroReport 11, 3539-3543 (2000).
17. Raffa, R.B., Walker, E.A. & Sterious, S.N. Opioid receptors and acetaminophen. Eur. J. Pharmacol. 503, 209-210 (2004).
18. Alloui, A., Pelissier, T., Dubray, C., Lavarenne, J. & Eschalier, A. Tropisetron inhibits the antinociceptive effect of intrathecally administered acetaminophen and serotonin. Fundam. Clin. Pharmacol. 10, 406-407 (1996).
19. Pelissier, T. et al. Acetaminophen exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence. J. Pharmacol. Exp. Ther. 278, 8-14 (1996).
20. Carlsson, K.H. & Jurna, I. Central analgesic effect of acetaminophen manifested by depression of nociceptive activity in thalamic neurones of the rat. Neurosci. Lett. 77, 339-343 (1987).
21. Courade, J.P., Chassaing, C., Bardin, L., Alloui, A. & Eschalier, A 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats. Eur. J. Pharmacol. 432, 1-7 (2001).
22. Bonnefont, J., Chapuy, E., Clottes, E., Alloui, A. & Eschalier, A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of acetaminophen, venlafaxine and 5-HT. Pain 114, 482-490 (2005).
23. Simpson, K., Spencer, C.M. & McClellan, K.J. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs 59, 1297-1315 (2000).
24. Graham, G.G. & Scott, K.F. Mechanism of action of acetaminophen. Am. J. Ther. 12, 46-55 (2005).
25. Barkhudaryan, N. & Dunn, A.J. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem. Res. 24, 1169-1180 (1999).
26. Bonnefont, J. et al. Acetaminophen recruits spinal p42/p44 MAPKs and GH/IGF-1 receptors to produce analgesia via the serotonergic system. Mol. Pharmacol. 71, 407-415 (2007).
27. Raffa, R.B. & Codd, E.E. Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays). Life Sci. 59, PL37-PL40 (1996).
28. Brink, T.S., Hellman, K.M., Lambert, A.M. & Mason, P. Raphe magnus neurons help protect reactions to visceral pain from interruption by cutaneous pain. J. Neurophysiol. 96, 3423-3432 (2006).
29. Piguet, V., Desmeules, J. & Dayer, P. Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex. Eur. J. Clin. Pharmacol. 53, 321-324 (1998).
30. Juhl, G.I., Norholt, S.E., Tonnesen, E., Hiesse-Provost, O. & Jensen, T.S. Analgesic efficacy and safety of intravenous paracetamol (acetaminophen) administered as a 2 g starting dose following third molar surgery. Eur. J. Pain. 10, 371-377 (2006).
31. Kees, F., Farber, L., Bucher, M., Mair, G., Morike, K. & Grobecker, H. Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers. Br. J. Clin. Pharmacol. 52, 705-707 (2001).
32. Kaiser, R. et al. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J. Clin. Oncol. 20, 2805-2811 (2002).
33. Sachse, C., Brockmoller, J., Bauer, S. & Roots, I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60, 284-295 (1997).
34. Marez, D. et al. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7, 193-202 (1997).
35. Douglas, A.M., Atchison, B.A., Somogyi, A.A. & Drummer, O.H. Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism. Pharmacogenetics 4, 154-158 (1994).
36. Johansson, I., Lundqvist, E., Dahl, M.L. & Ingelman-Sundberg, M. PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 6, 351-355 (1996).